收稿日期: 2025-06-16
网络出版日期: 2025-10-10
基金资助
厦门市卫生健康高质量发展科技计划项目(2024GZL-CX56)
The predictive value of the neutrophil⁃to⁃platelet ratio combined with C⁃reactive protein for the risk of death in patients with lower extremity arteriosclerosis obliterans
Received date: 2025-06-16
Online published: 2025-10-10
目的 探讨中性粒细胞/血小板比值(NPR)联合C反应蛋白(CRP)在下肢动脉硬化闭塞症(ASO)患者预后中的预测价值。 方法 回顾性分析2020年1月至2024年2月复旦大学附属中山医院(厦门)重症医学科收治的209例下肢ASO患者的临床资料。根据患者本次住院预后情况分为生存组和死亡组。计算入重症医学科当天的NPR并收集该日的CRP,比较两组NPR、CRP及NPR联合CRP的差异。通过受试者工作特征曲线(ROC)分析NPR、CRP及NPR联合CRP对下肢ASO患者预后的预测价值,根据NPR联合CRP的ROC曲线的截断值将患者分成两组,使用Kaplan-Meier法对两组患者进行生存分析。 结果 生存组患者的NPR、CRP、谷丙转氨酶、谷草转氨酶、肌酐、B型钠尿肽、肌钙蛋白、降钙素原及合并肾脏病比例明显低于死亡组(P < 0.05);白蛋白明显高于死亡组(P < 0.05)。二元logistic回归分析结果显示,NPR、CRP、NPR联合CRP、合并肾脏病比例是影响患者生存预后的独立危险因素。ROC曲线结果显示,NPR、CRP、NPR联合CRP曲线下面积分别为0.648、0.812、0.828,其中CRP、NPR联合CRP具有统计学意义(P < 0.05)。与单独NPR或CRP对比,NPR联合CRP具有更好的预测价值。根据NPR联合CRP的ROC曲线,通过最大约登指数确定截断值为0.029,依据截断值将患者分为高NPR + CRP组和低NPR + CRP组。通过Kaplan-Meier生存曲线对两组患者住院期间的生存率进行分析,结果显示,低NPR + CRP组患者的生存率明显高于高NPR + CRP组(P = 0.001)。 结论 NPR联合CRP与下肢ASO患者预后相关,可作为下肢ASO患者预后的有效预测指标。
关键词: 中性粒细胞/血小板比值; C反应蛋白; 下肢动脉硬化闭塞症; 预后
林雪烽 , 黄挺 . 中性粒细胞/血小板比值联合C反应蛋白对下肢动脉硬化闭塞症患者死亡风险的预测价值[J]. 实用医学杂志, 2025 , 41(19) : 3078 -3082 . DOI: 10.3969/j.issn.1006-5725.2025.19.018
Objective To investigate the prognostic significance of the neutrophil-to-platelet ratio (NPR) in combination with C-reactive protein (CRP) in patients with lower extremity arteriosclerosis obliterans (ASO). Methods A retrospective analysis was conducted on the clinical data of 209 patients with lower extremity ASO admitted to the Department of Critical Care Medicine at Zhongshan Hospital Affiliated to Fudan University (Xiamen) between January 2020 and February 2024. Patients were categorized into either the survival group or the death group based on their in-hospital prognosis. The NPR was calculated on the day of ICU admission, as was the level of CRP. Differences in NPR, CRP, and the combination of NPR and CRP between the two groups were then compared. The prognostic value of NPR, CRP, and their combined use for predicting outcomes in patients with lower extremity ASO was evaluated using receiver operating characteristic (ROC) curve analysis. Based on the optimal cutoff value derived from the ROC curve for the combination of NPR and CRP, patients were divided into two groups. Kaplan-Meier survival analysis was subsequently performed to assess differences in survival outcomes between these two groups. Results The levels of NPR, CRP, alanine aminotransferase, aspartate aminotransferase, creatinine, B-type natriuretic peptide, troponin, and procalcitonin, as well as the proportion of patients with kidney disease in the survival group, were significantly lower than those in the death group, and the differences were statistically significant (P < 0.05). The albumin level in the survival group was significantly higher than that in the death group, with a statistically significant difference (P < 0.05). Binary logistic regression analysis revealed that NPR, CRP, the combination of NPR and CRP, and the presence of comorbid kidney disease were independent risk factors influencing patient survival prognosis. ROC curve analysis showed that the areas under the curve (AUC) for NPR, CRP, and the combination of NPR and CRP were 0.648, 0.812, and 0.828, respectively. Both CRP and the combination of NPR and CRP demonstrated statistically significant (P < 0.05). Compared with either NPR or CRP alone, their combined use showed improved predictive performance. Based on the ROC curve for the combination of NPR and CRP, the optimal cutoff value was determined as 0.029 using the maximum Youden Index. Patients were then divided into high and low NPR + CRP groups according to this cutoff. Kaplan-Meier survival analysis revealed that the in-hospital survival rate in the low NPR + CRP group was significantly higher than that in the high NPR + CRP group, and the difference in survival between the two groups was statistically significant (P = 0.001). Conclusion NPR combined with CRP is associated with the prognosis of patients with lower extremity ASO and may serve as an effective predictive indicator for their clinical outcomes.
| [1] | LIAN W S, NIE H P, YUAN Y F, et al. Clinical Significance of Endothelin-1 And C Reaction Protein in Restenosis After the Intervention of Lower Extremity Arteriosclerosis Obliterans[J]. J Invest Surg, 2021, 34(7):765-770. doi:10.1080/08941939.2019.1690600 |
| [2] | SHAO C G, WUREN B T, CHI G Q, et al. Serum inflammatory factors such as MMP-9 are associated with post-percutaneous transluminal angioplastyacute myocardial infarction in coronary heart disease patients complicated by lower extremity arteriosclerosis obliterans[J]. Cell Mol Biol (Noisy-le-grand), 2023, 69(15):38-43. doi:10.14715/cmb/2023.69.15.6 |
| [3] | ARCHANA S M, MARTIN J S, JOSHUA A B, et al. Association between inflammatory biomarkers and all-cause, cardiovascular and cancer-related mortality[J]. CMAJ, 2017, 189(10): E384-E390. doi:10.1503/cmaj.160313 |
| [4] | AMIR A, SEYEDEH B T S, G-M MAJID, et al. Serum C-reactive protein in the prediction of cardiovascular diseases: Overview of the latest clinical studies and public health practice[J]. J Cell Physiol, 2018, 233(11):8508-8525. doi:10.1002/jcp.26791 |
| [5] | DONG Y, WANG X, ZHANG L F, et al. High-sensitivity C reactive protein and risk of cardiovascular disease in China-CVD study[J]. J Epidemiol Community Health, 2019, 73(2):188-192. doi:10.1136/jech-2018-211433 |
| [6] | IBRAHIM R, TUFAN ?, YAVUZ K. Endothelin-1 and C Reactive Protein as Potential Biomarkers for Restenosis in Patients with Arteriosclerosis Obliterans[J]. J Invest Surg, 2021, 34(7):771-772. doi:10.1080/08941939.2019.1693668 |
| [7] | MEAGHAN E C, BENJAMIN E T, YOGENDRA K. Inflammation, Infection and Venous Thromboembolism[J]. Circ Res, 2021, 128(12):2017-2036. doi:10.1161/circresaha.121.318225 |
| [8] | SEAN M M, ABHISHEK C. The role of platelet mediated thromboinflammation in acute liver injury[J]. Front Immunol, 2022, 13:1037645. doi:10.3389/fimmu.2022.1037645 |
| [9] | LINA B, ESTHER P, GEMMA A, et al. C-Reactive Protein in Atherothrombosis and Angiogenesis[J]. Front Immunol, 2018, 9:430. doi:10.3389/fimmu.2018.00430 |
| [10] | YE M, QIAN X, GUO X J, et al. Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio Predict Severity and Prognosis of Lower Limb Arteriosclerosis Obliterans[J]. Ann Vasc Surg, 2020, 64:221-227. doi:10.1016/j.avsg.2019.09.005 |
| [11] | SLAVEN P, LASZLO K S, MONIKA K O, et al. Neutrophil to lymphocyte ratio predicts intracranial hemorrhage after endovascular thrombectomy in acute ischemic stroke[J]. J Neuroinflammation, 2018, 15(1):319. doi:10.1186/s12974-018-1359-2 |
| [12] | SAFA K, CENAI Z, AARON M G, et al. Association Between Neutrophil-Lymphocyte Ratio and 30-Day Infection and Thrombotic Outcomes After Intraventricular Hemorrhage: A CLEAR III Analysis[J]. Neurocrit Care, 2024, 40(2):529-537. doi:10.1007/s12028-023-01774-6 |
| [13] | IBA T, LEVY J H. Inflammation and thrombosis: Roles of neutrophils, platelets and endothelial cells and their interactions in thrombus formation during sepsis[J]. J Thromb Haemost, 2018, 16(2):231-241. doi:10.1111/jth.13911 |
| [14] | BRAHM H S, THEJASWINI G, SORA S, et al. Neutrophil interactions with T cells, platelets, endothelial cells, and of course tumor cells[J]. Immunol Rev, 2023, 314(1):13-35. doi:10.1111/imr.13178 |
| [15] | INGRID S, JING W, ELZBIETA K, et al. Imaging the dynamic platelet-neutrophil response in sterile liver injury and repair in mice[J]. Hepatology, 2015, 62(5):1593-1605. doi:10.1002/hep.28003 |
| [16] | JAN R, ANDREAS M, ALEXANDER Z. Role of Platelets in Leukocyte Recruitment and Resolution of Inflammation[J]. Front Immunol, 2018, 9:2712. doi:10.3389/fimmu.2018.02712 |
| [17] | ZHANG D C, XU C L, DEEPA M, et al. Neutrophils, platelets, and inflammatory pathways at the nexus of sickle cell disease pathophysiology[J]. Blood, 2016, 127(7):801-809. doi:10.1182/blood-2015-09-618538 |
| [18] | CARSTEN D, PETER K, JULIA V, et al. Platelet secretion is crucial to prevent bleeding in the ischemic brain but not in the inflamed skin or lung in mice[J]. Blood, 2017, 129(12):1702-1706. doi:10.1182/blood-2016-12-750711 |
| [19] | JIN P, LI X, CHEN J, et al. Platelet-to-neutrophil ratio is a prognostic marker for 90-days outcome in acute ischemic stroke[J]. J Clin Neurosci, 2019, 63:110-115. doi:10.1016/j.jocn.2019.01.028 |
| [20] | LIN Y, DAI W, CHEN Y, et al. Neutrophil-to-platelet ratio predicts mortality following percutaneous coronary intervention in patients with acute ST-elevation myocardial infarction[J]. Front Physiol, 2022, 13:1011048. doi:10.3389/fphys.2022.1011048 |
| [21] | SOMASCHINI A, CORNARA S, DEMARCHI A, et al. Neutrophil to platelet ratio: A novel prognostic biomarker in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention[J]. Eur J Prev Cardiol, 2020, 27(19):2338-2340. doi:10.1177/2047487319894103 |
| [22] | LIU Y, JIA S D, YAO Y, et al. Impact of high-sensitivity C-reactive protein on coronary artery disease severity and outcomes in patients undergoing percutaneous coronary intervention[J]. J Cardiol, 2020, 75(1):60-65. doi:10.1016/j.jjcc.2019.06.012 |
| [23] | MUHAMMED S, CENGIZ B, AYCA G, et al. Prognostic value of C-reactive protein to albumin ratio for long-term outcomes of patients with peripheral arterial disease underwent endovascular treatment[J]. Vascular, 2022, 30(3):481-489. doi:10.1177/17085381211025172 |
| [24] | WANG A T, LIU J, LI C G, et al. Cumulative Exposure to High-Sensitivity C-Reactive Protein Predicts the Risk of Cardiovascular Disease[J]. J Am Heart Assoc, 2017, 6(10): e005610. doi:10.1161/jaha.117.005610 |
/
| 〈 |
|
〉 |